Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

IBM’s flight from healthcare shows AI must be local

IBM is on the retreat from its decade long AI in healthcare project: a multi-billion-dollar buy-and-build strategy to gather billions of data points fed into supercomputer Watson. Critics say the business has been unprofitable, overpromised and questioned how fit for purpose it is. HBI gets the inside track.

Amedes for sale as Synlab forecasts future organic growth to settle about 3%

Europe's largest lab group Synlab forecasts that it will see 3+% of annual organic growth over the mid-term, saying that testing will remain a core part of pandemic control. Other lab groups clearly agree with that punt, with news that smaller rival Amedes reportedly is preparing for sale.

Bergman buys German cosmetic group

Netherlands-based ambulatory and ophthalmology clinic group Bergman Clinics, currently exploring a sale that could raise over €1bn, has acquired German aesthetic surgical treatments platform Medical One.

Carlyle to exit Ameos in H2

Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.

Ameos sale/refinancing: Speculation mounts as group denies discussions

Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.

Aedifica takes first step into Ireland

Aedifica has acquired its first asset in Ireland. The Belgian REIT has taken ownership of an operational purpose-built care home in Mallow, County Cork in a deal worth approximately €25m.

Synlab and Cerba looking for exits, while Unilabs in ‘no rush’

The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite. 

Penta to sell stake in hospital business; IMs out by March

CEE private equity firm Penta Investments is seeking a new investor for its hospital division, Penta Hospitals International (PHI), and aims to launch a process with investment memorandums (IMs) out by the end of February, investment director Václav Jirků tells HBI. He discusses the reason for the sale, including international expansion, and the current political turmoil surrounding Penta and its healthcare business.

Find Us